© 1999 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Localization of Lipoprotein Lipase in the Diabetic Heart
Regulation by Acute Changes in Insulin
From the Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Correspondence to Dr B. Rodrigues, Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 E Mall, Vancouver, BC, Canada V6T 1Z3. E-mail rodrigue{at}unixg.ubc.ca
Abstract—Vascular endothelium–bound lipoprotein lipase (LPL) is rate limiting for free fatty acid (FFA) transport into tissues. In streptozotocin (STZ)-diabetic rats, we have previously demonstrated an increased heparin-releasable LPL activity from perfused hearts. Because heparin can traverse the endothelial barrier, conventional Langendorff retrograde perfusion of the heart with heparin could release LPL from both the capillary luminal and abluminal surfaces. To determine the precise location of the augmented LPL, a modified Langendorff retrograde perfusion was used to isolate the enzyme at the coronary lumen from that in the interstitial effluent. In response to heparin, a 4-fold increase in LPL activity and protein mass was observed in the coronary perfusate after 2 weeks of STZ diabetes. Release of LPL activity into the interstitial fluid of control hearts was slow but progressive, whereas in diabetic hearts, peak enzyme activity was observed within 1 to 2 minutes after heparin, followed by a gradual decline. Immunohistochemical studies of myocardial sections confirmed that the augmented LPL in diabetic hearts was mainly localized at the capillary endothelium. To study the acute effects of insulin on endothelial LPL activity, we examined rat hearts at various times after the onset of hyperglycemia. An increased heparin-releasable LPL activity in diabetic rats was demonstrated shortly (6 to 24 hours) after STZ injection or after withdrawal from exogenous insulin. Heparin-releasable coronary LPL activity was also increased after an overnight fast. These studies indicate that the intravascular heparin-releasable fraction of cardiac LPL activity is acutely regulated by short-term changes in insulin rather than glucose. Thus, during short periods (hours) of hypoinsulinemia, increased LPL activity at the capillary endothelium can increase the delivery of FFAs to the heart. The resultant metabolic changes could induce the subsequent cardiomyopathy that is observed in the chronic diabetic rat.
Key Words: lipoprotein lipase • diabetes • Langendorff perfused heart • insulin
This article has been cited by other articles:
 |
|
 |
|
  M. S. Kim, F. Wang, P. Puthanveetil, G. Kewalramani, E. Hosseini-Beheshti, N. Ng, Y. Wang, U. Kumar, S. Innis, C. G. Proud, et al. Protein Kinase D Is a Key Regulator of Cardiomyocyte Lipoprotein Lipase Secretion After Diabetes Circ. Res., August 1, 2008; 103(3): 252 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kewalramani, P. Puthanveetil, M. S. Kim, F. Wang, V. Lee, N. Hau, E. Beheshti, N. Ng, A. Abrahani, and B. Rodrigues Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E137 - E147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani, and B. Rodrigues Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase Dependent Actin Cytoskeleton Organization Diabetes, January 1, 2008; 57(1): 64 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Kim, C. Nian, and C. H. S. McIntosh Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes: A ROLE FOR A PROTEIN KINASE B, LKB1, AND AMP-ACTIVATED PROTEIN KINASE CASCADE J. Biol. Chem., March 23, 2007; 282(12): 8557 - 8567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pulinilkunnil and B. Rodrigues Cardiac lipoprotein lipase: Metabolic basis for diabetic heart disease Cardiovasc Res, February 1, 2006; 69(2): 329 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Sullivan, T. H. Teal, I. P. Luttrell, K. B. Tran, M. A. Peters, and H. Wessells Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats Physiol Genomics, October 17, 2005; 23(2): 192 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Pappan, Z. Pan, G. Kwon, C. A. Marshall, T. Coleman, I. J. Goldberg, M. L. McDaniel, and C. F. Semenkovich Pancreatic {beta}-Cell Lipoprotein Lipase Independently Regulates Islet Glucose Metabolism and Normal Insulin Secretion J. Biol. Chem., March 11, 2005; 280(10): 9023 - 9029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. An, T. Pulinilkunnil, D. Qi, S. Ghosh, A. Abrahani, and B. Rodrigues The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E246 - E253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Qi, T. Pulinilkunnil, D. An, S. Ghosh, A. Abrahani, J. A. Pospisilik, R. Brownsey, R. Wambolt, M. Allard, and B. Rodrigues Single-Dose Dexamethasone Induces Whole-Body Insulin Resistance and Alters Both Cardiac Fatty Acid and Carbohydrate Metabolism Diabetes, July 1, 2004; 53(7): 1790 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pulinilkunnil, D. Qi, S. Ghosh, C. Cheung, P. Yip, J. Varghese, A. Abrahani, R. Brownsey, and B. Rodrigues Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining Cardiovasc Res, September 1, 2003; 59(3): 788 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Neitzel, A. N. Carley, and D. L. Severson Chylomicron and palmitate metabolism by perfused hearts from diabetic mice Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E357 - E365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sambandam, M. A. Abrahani, S. Craig, O. Al-Atar, E. Jeon, and B. Rodrigues Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1874 - H1882. [Abstract] [Full Text] [PDF]
|
|